{
  "_id": "your_id",
  "variant_id": {
    "Gene": "EGFR",
    "Protein_Change": {
      "ref": "L",
      "alt": "R",
      "position": "858"
    },
    "variant_string_id": "R1441C"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "Autocatalytic and pathogenic mutations in LRRK2 are associated with Parkinson's disease.",
      "judgment": "Yes",
      "reasoning": "The paper clearly defines the relationship between these mutations and Parkinson's disease."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "This study uses biochemical interaction assays for protein-protein interactions.",
      "judgment": "Yes",
      "reasoning": "The paper employs biochemical interaction assays, which are generally applicable to this context."
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "Multiple replicates (n=3) include both wild-type and abnormal mutants.",
      "judgment": "Yes",
      "reasoning": "The study includes multiple replicates with appropriate controls for the assay."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3 Supporting"
  },
  "overall_conclusion": "The mutation of R1441C in EGFR disrupts endogenous LRRK2 binding to 14-3-3 isoforms, leading to accumulation within inclusion bodies and reduced intrinsic activity."
}